Study drug was permanently discontinued due to an adverse event in 15.5% of semaglutide tablets-treated patients and 11.6% of placebo-treated patients
Neurochem Res 43:12101226 Valerio A, Bertolotti P, Delbarba A, Perego C, Dossena M, Ragni M, Spano P, Carruba MO, De Simoni MG, Nisoli E (2011) Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production
Xiong, M
Also eat sulfur-containing foods (garlic, onions) to support glutathione production
Vomiting and Diarrhea: These symptoms can take place as your body adjusts to the medication
The Long-Term Consideration Studies show that one year after stopping the medication, participants regained two-thirds of their prior weight loss